Related Experiment Video
Updated: Jun 5, 2026

08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
Protein expression profiling in chemical carcinogenesis: a proteomic-based approach.
Simone Schmitz-Spanke1, Albert W Rettenmeier
1Institute of Hygiene and Occupational Medicine, University Hospital Essen, Essen, Germany. simone.schmitz-spanke@uk-essen.de
Proteomics
|January 20, 2011
Summary
Proteomic studies reveal common cellular responses like stress and inflammation to chemical carcinogens. Targeted proteomic approaches are crucial for understanding cancer development.
Area of Science:
- Toxicology
- Proteomics
- Cancer Research
Background:
- Simultaneous protein analysis offers insights into cellular system activation and suppression during disease progression.
- Proteomic studies in toxicology have focused on the effects of chemical carcinogens.
Purpose of the Study:
- To review proteomic study results concerning chemical carcinogen effects.
- To highlight the need for targeted proteomic approaches in chemical carcinogenesis research.
Main Methods:
- Review of existing proteomic studies.
- Identification of protein alterations in response to chemical carcinogens.
- Discussion of advanced techniques like selective reaction monitoring (SRM) and multiple reaction monitoring (MRM).
Main Results:
- Alterations in highly abundant proteins related to cellular stress response, inflammation, and immune system stimulation were identified.
- Observed protein alterations reflect common cellular reactions to perturbations, not causal factors in cancer development.
Conclusions:
- Current proteomic approaches need to shift from broad "shotgun" analyses to targeted methods for deeper insights.
- Advanced techniques like SRM and MRM hold potential for elucidating chemical carcinogenesis.
- Toxicoproteomic research advancements can contribute significantly to understanding cancer etiology.
More Related Videos
Related Concept Videos
Proteomics
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term proteomics...
Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...

